Citations

Clear

2391 citation(s) found for "Ma, Lin".

Update on Emerging Therapies for Advanced Colorectal Cancer
Alese, Olatunji B. , Ulanja, Mark B. , Zheng-Lin, Binbin , Amankwah, Millicent, Eads, Jennifer R. , Alese, Olatunji B , Wu, Christina , Chapin, William Joseph

Mayo Clinic

American Society of Clinical Oncology Educational Book | May 8, 2023 | Volume: No volume available | Issue: 43 | Pages: No page available

10.1200/edbk_389574 | PMID 37155942 Get It

Colorectal cancer (CRC) is the third most common malignancy worldwide. It is projected to increase by 3.2 million new cases and account for 1.6 million deaths by 2040. Mortality is largely due to limited treatment options for patients who present with advanced disease. Thus, the development of effective and tolerable therapies is crucial. Chemotherapy has been the backbone of systemic treatment of advanced CRC, but utility has been limited because of invariable resistance to therapy, narrow mechanisms of action, and unfavorable toxicity profile. Tumors that are mismatch repair-deficient have demonstrated remarkable response to immune checkpoint inhibitor therapy. However, most CRC tumors are mismatch repair-proficient and represent an unmet medical need. Although ERBB2 amplification occurs only in a few cases, it is associated with left-sided tumors and a higher incidence of brain metastasis. Numerous combinations of HER2 inhibitors have demonstrated efficacy, and antibody-drug conjugates against HER2 represent innovative strategies in this area. The KRAS protein has been classically considered undruggable. Fortunately, new agents targeting KRAS G12C mutation represent a paradigm shift in the management of affected patients and could lead the advancement in drug development for the more common KRAS mutations. Furthermore, aberrant DNA damage response is present in 15%-20% of CRCs, and emerging innovative combinations with poly (ADP-ribose) polymerase (PARP) inhibitors could improve the current therapeutic landscape. Multiple novel biomarker-driven approaches in the management of patients with advanced CRC tumors are reviewed in this article.
Methods for deriving risk difference (absolute risk reduction) from a meta-analysis
Murad, M. Hassan , Zhu, Ye, Saadi, Samer , Chu, Haitao , Lin, Lifeng , Chu, Haitao , Lin, Lifeng , Murad, M Hassan , Saadi, Samer , Wang, Zhen

Mayo Clinic

BMJ | May 5, 2023 | Volume: 381 | Issue: No issue available | Pages: e073141

10.1136/bmj-2022-073141 | PMID 37146999 Get It

Pulmonary Hypertension and Anastrozole (Phantom): A Randomized Clinical Trial
Kawut, S.M., Feng, Ruth, Zamanian, R.T., Ellenberg, S., Bull, T.M., Chakinala, Murali M. , Hemnes, A., Mathai, S.C., Lin, Grace , song, not provided Tao , DeMichele, A., Moutchia, J., Kawut, S.M., Feng, R., Mathai, S.C. , Austin, Eric , Moutchia, J, Ventetuolo, Corey E.

Mayo Clinic

D106. HOT OFF THE PRESSES! LATE BREAKERS IN PULMONARY VASCULAR DISEASE | May 1, 2023 | Volume: No volume available | Issue: No issue available | Pages: A6727-A6727

10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a6727 Get It

Caring for Critically Ill Children With the ICU Liberation Bundle (ABCDEF): Results of the Pediatric Collaborative*
Srivastava, Avantika , Jennison, Susan, Simino, Megan, Traube, Chani , LaRose, Kimberly, Kawai, Yu , Neu, Lori, Kudchadkar, Sapna R. , Wieczorek, Beth, Hajnik, Krista, Kordik, Christina, Kumar, Vishakha K. , Aghamohammadi, Sara, Arteaga, Grace M. , Smith, Heidi A. B. , Orman, Andrea, Landman, Becky McGee, Valdivia, Hector , Browne, H Ilayward's, Fang, Timothy, Zimmerman, Jerry J. , Collaborative, for the Society of Critical Care Medicine’s Pediatric ICU Liberation Campaign, Landman, Bennett A , Lin, John C. H. , Malone, Sara M. , Spentzas, Thomas , Collaborative, for the Society of Critical Care Medicine’s Pediatric ICU Liberation Campaign

Mayo Clinic

Pediatric Critical Care Medicine | May 1, 2023 | Volume: 24 | Issue: 8 | Pages: 636-651

10.1097/pcc.0000000000003262 | PMID 37125798 Get It

OBJECTIVES: Assess clinical outcomes following PICU Liberation ABCDEF Bundle utilization. DESIGN: Prospective, multicenter, cohort study. SETTING: Eight academic PICUs. PATIENTS: Children greater than 2 months with expected PICU stay greater than 2 days and need for mechanical ventilation (MV). INTERVENTIONS: ABCDEF Bundle implementation. MEASUREMENT AND MAIN RESULTS: Over an 11-month period (3-mo baseline, 8-mo implementation), Bundle utilization was measured for 622 patients totaling 5,017 PICU days. Risk of mortality was quantified for 532 patients (4,275 PICU days) for correlation between Bundle utilization and MV duration, PICU length of stay (LOS), delirium incidence, and mortality. Utilization was analyzed as subject-specific (entire PICU stay) and day-specific (single PICU day). Median overall subject-specific utilization increased from 50% during the 3-month baseline to 63.9% during the last four implementation months ( p < 0.001). Subject-specific utilization for elements A and C did not change; utilization improved for B (0–12.5%; p = 0.007), D (22.2–61.1%; p < 0.001), E (17.7–50%; p = 0.003), and F (50–79.2%; p = 0.001). We observed no association between Bundle utilization and MV duration, PICU LOS, or delirium incidence. In contrast, on adjusted analysis, every 10% increase in subject-specific utilization correlated with mortality odds ratio (OR) reduction of 34%, p < 0.001; every 10% increase in day-specific utilization correlated with a mortality OR reduction of 1.4% ( p = 0.006). CONCLUSIONS: ABCDEF Bundle is applicable to children. Although enhanced Bundle utilization correlated with decreased mortality, increased utilization did not correlate with duration of MV, PICU LOS, or delirium incidence. Additional research in the domains of comparative effectiveness, implementation science, and human factors engineering is required to understand this clinical inconsistency and optimize PICU Liberation concept integration into clinical practice.
Higher Degree of Carotid Artery Stenosis is Associated with Worse Cognition (S45.005)
Mateti, Nihas, Barrett, Kevin M. , Taner, Nilüfer, Brott, Thomas G. , Lin, Michelle , Erben, Young , Meschia, James F.

Mayo Clinic

Neurology | April 28, 2023 | Volume: 100 | Issue: 17_supplement_2 | Pages: No page available

10.1212/wnl.0000000000203720 Get It

Differential Effect of Stroke Types on Cerebral White Matter Disease Progression (S45.001)
Elkhair, Ahamed, Youssef, Hossam , Anisetti, Bhrugun , Salem, Amr , Mateti, Nihas, Youseff, Hossam , Lin, Michelle

Mayo Clinic

Neurology | April 28, 2023 | Volume: 100 | Issue: 17_supplement_2 | Pages: No page available

10.1212/wnl.0000000000203696 Get It

Protective Effect of APOE-ɛ2 on Cortical Thickness and Volume in a Cerebrovascular Registry (S36.010)
Youssef, Hossam , Mateti, Nihas, Middlebrooks, Erik H. , Taner, Nilüfer, Middlebrooks, Erik H , Youseff, Hossam , Meschia, James F. , Lin, Michelle

Mayo Clinic

Neurology | April 28, 2023 | Volume: 100 | Issue: 17_supplement_2 | Pages: No page available

10.1212/wnl.0000000000203689 Get It

Abnormal Left Ventricular Geometry is Associated with Cerebral White Matter Disease (S36.005)
Salem, Amr , Mateti, Nihas, Demirer, Mutlu , Anisetti, Bhrugun , Youssef, Hossam , Elkhair, Ahamed, Youseff, Hossam , Adedinsewo, Demilade , Meschia, James F. , Lin, Michelle

Mayo Clinic

Neurology | April 28, 2023 | Volume: 100 | Issue: 17_supplement_2 | Pages: No page available

10.1212/wnl.0000000000203017 Get It

Age-related Macular Degeneration, Incident Ischemic Stroke, and Cognitive impairment (P14-5.024)
Anisetti, Bhrugun , Stewart, Michael G. , Eggenberger, Eric , Taner, Nilüfer, Meschia, James F. , Lin, Michelle

Mayo Clinic

Neurology | April 28, 2023 | Volume: 100 | Issue: 17_supplement_2 | Pages: No page available

10.1212/wnl.0000000000202641 Get It

Framingham Risk Score and White Matter Disease Progression (P11-5.009)
Youssef, Hossam , Mateti, Nihas, Mutlu, Demirer, Middlebrooks, Erik H. , Brott, Thomas G. , Taner, Nilüfer, Middlebrooks, Erik H , Youseff, Hossam , Meschia, James F. , Lin, Michelle

Mayo Clinic

Neurology | April 28, 2023 | Volume: 100 | Issue: 17_supplement_2 | Pages: No page available

10.1212/wnl.0000000000202478 Get It